HomeInvestingEarningsNBIX, TVTX, ARDX, BIIB: Biotech Stocks Ahead Of 3Q Earnings

NBIX, TVTX, ARDX, BIIB: Biotech Stocks Ahead Of 3Q Earnings

Neurocrine Biosciences’ (NBIX) recent pipeline wins are a nice way to end the year, notes Wedbush’s Laura Chico. She discusses the outlook for biotech stocks ahead of 3Q earnings. Wedbush has an outperform rating and a $137 price target on NBIX. She then looks at Travere Therapeutics (TVTX). She highlights that while shares continue to trade in the $7/share range, we see a compelling entry point at the present. She also talks about Ardelyx (ARDX) which she says that its improving gross/net discount could also provide a tailwind as we wait the Xphozah launch commencement in November. Additionally, she mentions that Wedbush is looking for a slight 3Q revenue miss for Biogen (BIIB). Tune in to find out more about the stock market today.

Market On Close

24 Oct 2023

SHARE

ON AIR
5:00 am
Next Gen Investing
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
ON AIR
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
4:30 pm
Market Overtime
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now